Related Experiment Video
Updated: Oct 16, 2025

Immunolabelling Myofiber Degeneration in Muscle Biopsies
Published on: December 5, 2019
The Immune System in Duchenne Muscular Dystrophy Pathogenesis.
Luana Tripodi1, Chiara Villa1, Davide Molinaro1
1Laboratorio di Cellule Staminali, Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Centro Dino Ferrari, Via Francesco Sforza 35, 20122 Milan, Italy.
Duchenne Muscular Dystrophy (DMD) involves immune system activation and T-lymphocyte defects. Understanding this immune-skeletal muscle crosstalk offers new clinical insights for DMD treatment.
Area of Science:
- Immunology
- Muscle Biology
- Genetics
Background:
- Immune system and skeletal muscle crosstalk is evident in muscle diseases like Duchenne Muscular Dystrophy (DMD).
- Inflammation and immune cell infiltration (T cells, macrophages, etc.) are key features of DMD pathology.
- Traditionally viewed as a consequence, immune activation in DMD may stem from central tolerance defects.
Purpose of the Study:
- To review recent advancements in understanding immune system involvement in DMD pathogenesis.
- To explore the complex relationship between innate and adaptive immunity in DMD.
- To identify potential new clinical opportunities arising from this knowledge.
Main Methods:
- Literature review of recent studies on immune responses in DMD.
- Analysis of immune cell infiltration and function in skeletal muscle.
- Examination of central tolerance mechanisms and T-lymphocyte autoreactivity in DMD.
Main Results:
- DMD involves significant immune cell infiltration and activation within skeletal muscle.
- Evidence suggests thymus alterations and autoreactive T-lymphocytes contribute to DMD.
- The severity of muscle injury correlates with impaired regeneration and tissue replacement.
Conclusions:
- Immune system dysregulation is a critical factor in DMD pathogenesis, not just a consequence.
- Further research into immune-skeletal muscle interactions can reveal novel therapeutic targets for DMD.
- Understanding central tolerance defects opens new avenues for clinical intervention in DMD.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myocarditis I: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

